NHNSENarayana Hrudayalaya Ltd.· Healthcare ServicesHighNeutral
Announced Fri, 12 Dec, 2025 · 20:45 IST

Board approves demerger of NHIC clinical services business into NHL

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

NH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.9%Reaction day
₹1870.00
prior close
₹1863.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.4%+1.6% vs market
Hospital peers, median of 21sector+0.3%+1.7% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty Smallcap 250 and 1.7 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
+0.0
15m
+0.1
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.9+0.4+1.6+0.3+1.7
Next day
+1.3-0.4+1.7-0.4+1.7
2d
+0.4-1.1+1.5-1.3+1.6
3d
-1.7-1.2-0.5-2.5+0.8
4d
+2.7+0.1+2.6-2.3+5.0
5d
+1.3+1.0+0.3-1.7+3.0
1w
+0.3+1.5-1.2-1.8+2.1
15d
+3.7+2.4+1.3-2.9+6.6
1m
+2.4-1.2+3.6-7.3+9.7
2m
-2.1-2.5+0.5-10.1+8.1
3m
-12.0-9.7-2.3-17.5+5.5
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Narayana Hrudayalaya's board approved a scheme to demerge subsidiary NH Integrated Care's Clinical Services business (10 Bengaluru clinics) into itself. Demerged turnover: Rs 39.94 crore (about 1.11% of FY25 standalone turnover). As NHIC is wholly-owned, no shares or cash change hands. Post-demerger, NHIC will focus on the Aarogyam preventive platform, while NHL folds clinics into its hospital network. Appointed date April 1, 2025. Awaits NCLT nod.

Likely market impact

Pure internal restructuring with no share dilution, no cash outflow, and no change in promoter holding. Subject to NCLT approval.